Dermatology Eponyms – sign –Lexicon (R). Part 2
Journal Title: Nasza Dermatologia Online - Year 2017, Vol 8, Issue 1
Abstract
Eponyms are used almost daily in the clinical practice of dermatology. And yet, information about the person behind the eponyms is difficult to find. Indeed, who is? What is this person’s nationality? Is this person alive or dead? How can one find the paper in which this person first described the disease? Eponyms are used to describe not only disease, but also clinical signs, surgical procedures, staining techniques, pharmacological formulations, and even pieces of equipment. In this article we present the symptoms starting with (R) and other. The symptoms and their synonyms, and those who have described this symptom or phenomenon.
Authors and Affiliations
Piotr Brzeziński Brzeziński
Dermoscopic findings in extragenital lichen sclerosus
Lichen sclerosus (LS), also known as lichen sclerosus et atrophicus is a chronic inflammatory dermatosis of unknown aetiology. It has both genital and extragenital presentations, nevertheless genital forms significantly...
Acne inversa (Hurley clinical stage II ): case report
We present a case of acne inversa Hurley clinical stage II, to a 28 year-old patient non-obese, smoker, with a long history of firm nodules, large abscesses and sinous tracts, small scars, distributed in the axillary,...
Study of fractional ablative laser in surgical and post traumatic scar
Introduction: Ablative, fractional lasers generate microscopic columns of coagulated tissue through the epidermis and dermis to evoke a wound healing response. In this study, we examined the efficacy and safety of...
LAT, EGFR -pY197, PCNL2, CDX2, HLA-DPDQDR, bromodeoxyuridine, JAM-A, and ezrin immunoreactants in a rubbed spongiotic dermatitis
Background: Acute and subacute spongiotic dermatitides are among the most commonly diagnosed types of dermatitis. Many patients rub their lesions, with the lesions becoming clinically thickened. The precise immunologic m...
Six cases of purpuric eruptions induced by epidermal growth factor receptor inhibitors
-